Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ROPN1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DHRS4L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EHD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102606465 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA1549L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGFBP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPS23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIG3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ABLIM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDCD4-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL51 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UGGT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBC1D16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARVB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on